Institute for Drug Discovery, Medical Faculty, Leipzig University, Brüderstraße 34, 04103, Leipzig, Germany.
Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, 40225, Düsseldorf, Germany.
Angew Chem Int Ed Engl. 2020 Dec 7;59(50):22494-22499. doi: 10.1002/anie.202006725. Epub 2020 Oct 9.
Inhibition of more than one cancer-related pathway by multi-target agents is an emerging approach in modern anticancer drug discovery. Here, based on the well-established synergy between histone deacetylase inhibitors (HDACi) and alkylating agents, we present the discovery of a series of alkylating HDACi using a pharmacophore-linking strategy. For the parallel synthesis of the target compounds, we developed an efficient solid-phase-supported protocol using hydroxamic acids immobilized on resins (HAIRs) as stable and versatile building blocks for the preparation of functionalized HDACi. The most promising compound, 3 n, was significantly more active in apoptosis induction, activation of caspase 3/7, and formation of DNA damage (γ-H2AX) than the sum of the activities of either active principle alone. Furthermore, to demonstrate the utility of our preloaded resins, the HAIR approach was successfully extended to the synthesis of a proof-of-concept proteolysis-targeting chimera (PROTAC), which efficiently degrades histone deacetylases.
多靶点药物抑制多种癌症相关通路是现代抗癌药物研发中的一种新兴方法。在这里,基于组蛋白去乙酰化酶抑制剂(HDACi)和烷化剂之间已确立的协同作用,我们采用药效团连接策略发现了一系列烷化 HDACi。为了平行合成目标化合物,我们开发了一种有效的固相支持方案,使用固定在树脂上的羟肟酸(HAIRs)作为稳定且多功能的构建块,用于制备功能化的 HDACi。最有前途的化合物 3n 在诱导细胞凋亡、激活 caspase 3/7 和形成 DNA 损伤(γ-H2AX)方面的活性明显高于两种活性成分单独作用的总和。此外,为了证明我们预加载树脂的实用性,成功地将 HAIR 方法扩展到了证明概念的蛋白酶体靶向嵌合体(PROTAC)的合成中,该嵌合体有效地降解了组蛋白去乙酰化酶。